Advanced targeted therapies effective as first-line treatment for lung cancer
... cell division. IPASS is a randomized phase iii study that compared oral gefitinib with ... WITH CHEMOTHERAPY: RESULTS FROM THE PHASE iii SATURN STUDY (ABSTRACT # A2.1) Erlotinib is ... aimed at extending survival. The phase iii SATURN study was initiated to evaluate the ...Delcath Systems Provides Update on Progress
... 40 Additional Patients for Enrollment in Phase iii Metastatic Melanoma Trial Since Late April, ... patient enrollment milestones in our Phase iii Metastatic Melanoma Trial. Based on recent ... and I look forward to completing our Phase iii trial and submitting for FDA approval in a timely ...Children's Hospitals and Clinics of Minnesota Receive Level III Trauma Designation
... of Minnesota's two hospital locations as Level iii Trauma Hospitals. Children's of Minnesota has ... most important predictor of survival. The Level iii Trauma designation for Children's means children ... designation of Children's of Minnesota as a Level iii Trauma Hospital, we are getting closer to our ...Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
... bladder cancer that is currently undergoing Phase iii clinical testing. Under the agreement signed ... ." Bladder Cancer and the Ongoing Phase iii Clinical Program for Urocidin(TM) In ... into the bladder. The first of two Phase iii U.S. Food and Drug Administration (FDA)-approved ...Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
... The primary endpoint of the ASCEND II and iii studies was overall improvement at six weeks, ... and 75 percent of the patients in the ASCEND iii and ASCEND II studies, respectively. At six ... patients taking Asacol HD at 4.8 g/day in ASCEND iii and 79 percent of patients in ASCEND II ...Cynergy III Aesthetic Workstation
Description:... Cynergy iii brings it all together. Cynergy iii allows you to create a true modular ... and add-on pulsed light system, the Cynergy iii is the most exciting innovation in ...InSync III Cardiac Resynchronization System
Description:... The Medtronic InSync iii Model 8042 increases therapy versatility with ... sensing, pacing and cardiac output. The InSync iii system also offers unmatched insight through key ... to severe heart failure (NYHA Functional Class iii or IV) in those patients who remain symptomatic ...PSI-TEC III Tumescent Infiltrator System
Description:... The PSI-TEC iii Infiltrator is a compact system featuring easy setup and flow control. ... operation. Ideal for office or hospital use, the PSI-TEC iii Infiltrator combines a small footprint and ultra compact design - 5" (w) ...Lancet study supports new, highly effective treatment for blood disorder
... results of an international, multicenter Phase iii clinical trial, led by NewYork-Presbyterian/Weill ... to all of the experimental subjects in the Phase iii study. The Phase iii study tested 114 subjects, who were all 18 years ...Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections
... the combined results from two pivotal Phase iii clinical trials at the 48th Interscience ... and Skin Structure Infection STudy) pivotal Phase iii studies involving a total of 991 patients. In a ... at a dose of 0.8 mg/kg in the Phase iii ASSIST trials. Adverse events were found to be ...'Western' diet linked to increased risk of colon cancer recurrence
... Association, involved 1,009 patients with stage iii colon cancer that has been treated with both surgery and chemotherapy. Stage iii colon cancer is characterized as being localized ... participants, who were enrolled in a large, phase iii clinical trial sponsored by the National Cancer ...Details of bacterial 'injection' system revealed
... The scientists were studying a needlelike protein complex known as a "type iii secretion system," or T3SS, on the surface of Shigella bacteria, a cause ... Wall, a biophysicist at Brookhaven Lab. Previous studies of the type iii secretion system have revealed that it is composed of some 25 different ...Sanofi-aventis Announces Second Quarter 2009 Results
... launch of a new R&D approach ; start of Phase iii for BSI-201 in triple negative breast cancer; ... acquired by sanofi-aventis) entered Phase iii in July. This pivotal study will evaluate the ... the HER2 receptor. Enrolment to the Phase iii study, evaluating NV1FGF in critical ischemia of ...Schering-Plough Reports Financial Results for 2009 Second Quarter
... thrombin receptor antagonist (TRA), in Phase iii for atherothrombosis; SIMPONI (golimumab), a ... boceprevir, a protease inhibitor in Phase iii for hepatitis C; and BRIDION (sugammadex), an ... Initiation of patient enrollment in a Phase iii trial (RED-CABG) in May for acadesine, an ...BioMS Medical announces second quarter 2009 results
... months ended June 30, 2009. "The pivotal phase iii MAESTRO-01 trial has completed the last patient ... - MAESTRO-01: This pivotal phase iii trial is being conducted in Canada and ... August 1, 2008 for this pivotal U.S. phase iii trial of approximately 510 SPMS patients ...STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
... 2009 with the positive results of the phase iii clinical study carried out on the house dust mite ... a particularly busy news flow: 3 Oralair(R) phase iii studies (US, 3rd year of long-term ... time includes a recombinant allergen, and 1 phase iii Staloral(R) study on asthma, carried out in ....Johnson & Johnson Completes Acquisition of Cougar Biotechnology
... Biotechnology currently is conducting two Phase iii trials for abiraterone acetate, a late stage, ... treatment of prostate cancer. The first Phase iii trial is testing abiraterone acetate in patients ... chemotherapy has failed. The second Phase iii trial is studying abiraterone acetate in patients ...New Report Just Published: World Prostate Cancer Therapeutics Market Report
... Notable Prostate Cancer Drug Failures in Phase iii Development II-13 High Development Costs ... II-53 Debiopharm Unveils Results of Phase iii Study of Trelstar in Prostate Cancer ... in Prostate Cancer II-57 Novacea Starts Phase iii Clinical Trial for Treatment of Prostate ...DNA Exonuclease III , E. coli from EPICENTRE Biotechnologies
Description:... Exonuclease iii digests duplex DNA in a 3'-> 5' direction from a ... conditions, DNA degradation by Exonuclease iii proceeds at a uniform rate yielding predictable ... excision of deoxyribonucleotides by Exonuclease iii is dependent upon reaction factors including ...pMIR-hU6-Luc, Human U6 Luciferase Control Vector from Mirus Bio Corporation
Description:... transcription in the nucleus from RNA Polymerase iii promoters. An expression cassette is a DNA ... human U6, human H1, or mouse U6 RNA polymerase iii promoters. These promoters drive expression of ... Cassettes can be cloned using either the Hind iii or EcoR I site upstream of the promoter and Xho I ...Goat Anti-BRF2 Polyclonal Antibody, Unconjugated from GeneTex
Description:... Information BRF2 is one of the multiple subunits of the RNA polymerase iii transcription factor complex required for transcription of genes with ... initiation site. BRF2 is directly recruited to the TATA-box of polymerase iii small nuclear RNA gene promoters through its interaction with the ...RNase III, E. coli from EPICENTRE Biotechnologies
Description:... Ribonuclease iii (RNase III) from E. coli is an endoribonuclease that specifically digests ... Complete digestion of dsRNA results in dsRNA fragments of 12-15 bp. RNase iii can digest double-stranded RNA composed of canonical ribonucleotides as ...SuperScript III RNase H- Reverse Transcriptase from Invitrogen
Description:... SuperScript™ iii RNase H- Reverse Transcriptase (RT) is an improved version of ... from single-stranded RNA DNA or an RNA:DNA hybrid. SuperScript™ iii is genetically ...pMIR-mU6, Mouse U6Template (Vector) from Mirus Bio Corporation
Description:... that drive siRNA transcription in the nucleus from RNA Polymerase iii promoters [2,3,5-11]. An expression cassette is a DNA construct that ... cells have utilized the human U6, human H1, or mouse U6 RNA polymerase iii promoters. These promoters drive expression of short RNA transcripts that ...